Using an overexpression model in LNcaP cells they found that Etk/Bmx is an effector of PI3-kinase and that the PI3-kinase/Etk pathway is involved in the protection of prostate carcinoma cells from apoptosis in response to PDT. This evidence concerns the gene BMX and prostate carcinoma.